AKUS Akouos Inc

Price (delayed)

$3.97

Market cap

$137.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.83

Enterprise value

$109.76M

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss ...

Highlights
The company's EPS has surged by 77% YoY but it fell by 12% QoQ
The company's net income has shrunk by 80% YoY and by 13% QoQ
The quick ratio has plunged by 72% YoY and by 18% from the previous quarter

Key stats

What are the main financial stats of AKUS
Market
Shares outstanding
34.63M
Market cap
$137.47M
Enterprise value
$109.76M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.66
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$97.57M
EBITDA
-$93.54M
Free cash flow
-$75.58M
Per share
EPS
-$2.83
Free cash flow per share
-$2.19
Book value per share
$6.04
Revenue per share
$0
TBVPS
$7.41
Balance sheet
Total assets
$255.96M
Total liabilities
$46.97M
Debt
$29.13M
Equity
$208.98M
Working capital
$192.89M
Liquidity
Debt to equity
0.14
Current ratio
11.39
Quick ratio
11.4
Net debt/EBITDA
0.3
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-34%
Return on equity
-40%
Return on invested capital
-50.6%
Return on capital employed
-41.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AKUS stock price

How has the Akouos stock price performed over time
Intraday
-5.7%
1 week
9.97%
1 month
55.69%
1 year
-70.35%
YTD
-53.29%
QTD
-16.42%

Financial performance

How have Akouos's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$97.71M
Net income
-$97.57M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 80% YoY and by 13% QoQ
AKUS's operating income has dropped by 79% year-on-year and by 13% since the previous quarter

Growth

What is Akouos's growth rate over time

Valuation

What is Akouos stock price valuation
P/E
N/A
P/B
0.66
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 77% YoY but it fell by 12% QoQ
AKUS's price to book (P/B) is 49% lower than its last 4 quarters average of 1.3
AKUS's equity is down by 30% year-on-year and by 11% since the previous quarter

Efficiency

How efficient is Akouos business performance
Akouos's return on equity has shrunk by 133% YoY and by 23% QoQ
Akouos's return on assets has shrunk by 111% YoY and by 19% QoQ
The ROIC has plunged by 56% YoY and by 13% from the previous quarter

Dividends

What is AKUS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AKUS.

Financial health

How did Akouos financials performed over time
Akouos's total liabilities has surged by 87% YoY and by 4.1% QoQ
AKUS's current ratio has dropped by 72% year-on-year and by 19% since the previous quarter
Akouos's debt is 86% lower than its equity
Akouos's debt to equity has soared by 133% YoY and by 17% from the previous quarter
Akouos's debt has surged by 57% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.